메뉴 건너뛰기




Volumn 33, Issue 5, 2013, Pages 359-364

Long-term tolerability and safety of lamotrigine extended-release: Pooled analysis of three clinical trials

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE;

EID: 84877016242     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.1007/s40261-013-0070-4     Document Type: Article
Times cited : (16)

References (20)
  • 1
    • 44949169540 scopus 로고    scopus 로고
    • LAMICTAL (lamotrigine tablets) prescribing information September Accessed 25 Oct 2011
    • LAMICTAL (lamotrigine tablets) prescribing information. GlaxoSmithKline: September 2011. http://www.gsk.com/products/prescription-medicines/lamictal.htm. Accessed 25 Oct 2011.
    • (2011) GlaxoSmithKline
  • 2
    • 44949169540 scopus 로고    scopus 로고
    • LAMICTAL XR (lamotrigine) extended-release tablets prescribing information September Accessed 25 Oct 2011
    • LAMICTAL XR (lamotrigine) extended-release tablets prescribing information. GlaxoSmithKline: September 2011. http://www.gsk.com/products/ prescription-medicines/lamictal.htm. Accessed 25 Oct 2011.
    • (2011) GlaxoSmithKline
  • 3
    • 39749110172 scopus 로고    scopus 로고
    • Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (the COMPASS study)
    • 17825077 10.1111/j.1528-1167.2007.01274.x 1:CAS:528:DC%2BD1cXktVOjs7Y%3D
    • Tompson DJ, Ali I, Oliver-Willwong R, et al. Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (the COMPASS study). Epilepsia. 2008;49:410-7.
    • (2008) Epilepsia , vol.49 , pp. 410-417
    • Tompson, D.J.1    Ali, I.2    Oliver-Willwong, R.3
  • 4
    • 60549112029 scopus 로고    scopus 로고
    • Once-daily lamotrigine extended release for epilepsy management
    • 19210192 10.1586/14737175.9.2.167 1:CAS:528:DC%2BD1MXhslyisrs%3D
    • Rheims S, Ryvlin P. Once-daily lamotrigine extended release for epilepsy management. Expert Rev Neurother. 2009;9:167-73.
    • (2009) Expert Rev Neurother , vol.9 , pp. 167-173
    • Rheims, S.1    Ryvlin, P.2
  • 5
    • 0034871011 scopus 로고    scopus 로고
    • A systematic review of the associations between dose regimens and medication compliance
    • 11558866 10.1016/S0149-2918(01)80109-0 1:STN:280:DC%2BD3MrhtVKktA%3D%3D
    • Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296-310.
    • (2001) Clin Ther , vol.23 , pp. 1296-1310
    • Claxton, A.J.1    Cramer, J.2    Pierce, C.3
  • 6
    • 0028889303 scopus 로고
    • Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial
    • 7588455 10.1111/j.1528-1157.1995.tb00469.x 1:CAS:528:DyaK2MXpsl2ktr8%3D
    • Cramer J, Vachon L, Desforges C, et al. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia. 1995;36:1111-7.
    • (1995) Epilepsia , vol.36 , pp. 1111-1117
    • Cramer, J.1    Vachon, L.2    Desforges, C.3
  • 7
    • 0033868589 scopus 로고    scopus 로고
    • Antiepileptic drug treatment: Outcomes and adherence
    • 10937819 10.1592/phco.20.12.191S.35250 1:CAS:528:DC%2BD3cXlvVyhur0%3D
    • Garnett WR. Antiepileptic drug treatment: outcomes and adherence. Pharmacotherapy. 2000;20:191S-9S.
    • (2000) Pharmacotherapy , vol.20
    • Garnett, W.R.1
  • 8
    • 0030978056 scopus 로고    scopus 로고
    • Factors influencing compliance with antiepileptic drug regimes
    • 9153719 10.1016/S1059-1311(97)80060-X 1:STN:280:DyaK2s3pvVaksw%3D%3D
    • Buck D, Jacoby A, Baker GA, Chadwick DW. Factors influencing compliance with antiepileptic drug regimes. Seizure. 1997;6:87-93.
    • (1997) Seizure , vol.6 , pp. 87-93
    • Buck, D.1    Jacoby, A.2    Baker, G.A.3    Chadwick, D.W.4
  • 9
    • 0036669376 scopus 로고    scopus 로고
    • The relationship between poor medication compliance and seizures
    • Cramer JA, Glassman M, Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav. 2002;3:228-42.
    • (2002) Epilepsy Behav , vol.3 , pp. 228-242
    • Cramer, J.A.1    Glassman, M.2    Rienzi, V.3
  • 10
    • 33645580598 scopus 로고    scopus 로고
    • Variability of antiepileptic medication-taking behaviour in sudden unexplained death in epilepsy: Hair analysis at autopsy
    • 16543526 10.1136/jnnp.2005.067777 1:STN:280:DC%2BD287lsVWmtw%3D%3D
    • Williams J, Lawthom C, Dunstan FD, et al. Variability of antiepileptic medication-taking behaviour in sudden unexplained death in epilepsy: hair analysis at autopsy. J Neurol Neurosurg Psychiatry. 2006;77:481-4.
    • (2006) J Neurol Neurosurg Psychiatry , vol.77 , pp. 481-484
    • Williams, J.1    Lawthom, C.2    Dunstan, F.D.3
  • 11
    • 35848947010 scopus 로고    scopus 로고
    • Lamotrigine extended-release as adjunctive therapy for partial seizures
    • 17938371 10.1212/01.wnl.0000277698.33743.8b 1:CAS:528:DC%2BD2sXhtFekt73M
    • Naritoku DK, Warnock CR, Messenheimer JA, et al. Lamotrigine extended-release as adjunctive therapy for partial seizures. Neurology. 2007;69:1610-8.
    • (2007) Neurology , vol.69 , pp. 1610-1618
    • Naritoku, D.K.1    Warnock, C.R.2    Messenheimer, J.A.3
  • 12
    • 78649904882 scopus 로고    scopus 로고
    • Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study
    • 20937567 10.1016/j.yebeh.2010.07.022
    • Biton V, DiMemmo J, Shukla R, et al. Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study. Epilepsy Behav. 2010;19:352-8.
    • (2010) Epilepsy Behav , vol.19 , pp. 352-358
    • Biton, V.1    Dimemmo, J.2    Shukla, R.3
  • 13
    • 84856611764 scopus 로고    scopus 로고
    • Lamotrigine XR conversion to monotherapy: First study using a historical control group
    • 22139591 10.1007/s13311-011-0088-3 1:CAS:528:DC%2BC38XhvFantrg%3D
    • French JA, Temkin N, Shneker BF, et al. Lamotrigine XR conversion to monotherapy: first study using a historical control group. Neurotherapeutics. 2012;9:176-84.
    • (2012) Neurotherapeutics , vol.9 , pp. 176-184
    • French, J.A.1    Temkin, N.2    Shneker, B.F.3
  • 15
    • 0031955433 scopus 로고    scopus 로고
    • Safety review of adult clinical trial experience with lamotrigine
    • 9565739 10.2165/00002018-199818040-00004 1:CAS:528:DyaK1cXislCjs7Y%3D
    • Messenheimer J, Mullens EL, Giorgi L, et al. Safety review of adult clinical trial experience with lamotrigine. Drug Saf. 1998;18:281-96.
    • (1998) Drug Saf , vol.18 , pp. 281-296
    • Messenheimer, J.1    Mullens, E.L.2    Giorgi, L.3
  • 16
    • 0021043873 scopus 로고
    • Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy
    • Keranen T, Sivenius J. Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy. Acta Neurol Scand Suppl. 1982;97:69-80.
    • (1982) Acta Neurol Scand Suppl , vol.97 , pp. 69-80
    • Keranen, T.1    Sivenius, J.2
  • 17
    • 0026013102 scopus 로고
    • A comparison of the efficacy and tolerability of controlled-release carbamazepine with conventional carbamazepine
    • 2036618 1:STN:280:DyaK3M3ktlSrsQ%3D%3D
    • Dhalla Z, Bruni J, Sutton J. A comparison of the efficacy and tolerability of controlled-release carbamazepine with conventional carbamazepine. Can J Neurol Sci. 1991;18:66-8.
    • (1991) Can J Neurol Sci , vol.18 , pp. 66-68
    • Dhalla, Z.1    Bruni, J.2    Sutton, J.3
  • 18
    • 56749112207 scopus 로고    scopus 로고
    • Pharmacotherapeutics of epilepsy: Use of lamotrigine and expectations for lamotrigine extended release
    • 19209284 1:CAS:528:DC%2BD1cXhsFers7zK
    • Werz MA. Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release. Ther Clin Risk Manag. 2008;4:1035-46.
    • (2008) Ther Clin Risk Manag , vol.4 , pp. 1035-1046
    • Werz, M.A.1
  • 19
    • 77958508858 scopus 로고    scopus 로고
    • Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients
    • Blaszczyck B, Czuczwar SJ. Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients. Neuropsychiatr Dis Treat. 2010;6:145-50.
    • (2010) Neuropsychiatr Dis Treat , vol.6 , pp. 145-150
    • Blaszczyck, B.1    Czuczwar, S.J.2
  • 20
    • 79952457600 scopus 로고    scopus 로고
    • Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures: Focus on once-daily lamotrigine
    • 21151621 1:CAS:528:DC%2BC3cXhsVOqtbrP
    • Steinbaugh L, Szaflarski JP. Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures: focus on once-daily lamotrigine. Drug Des Devel Ther. 2010;4:337-42.
    • (2010) Drug des Devel Ther , vol.4 , pp. 337-342
    • Steinbaugh, L.1    Szaflarski, J.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.